Stagend.com closes seed round
The goal of Stagend.com, a start-up from Ticino, is to allow artists, event organizers, and fans to save time, money, and work by simplifying daily operations surrounding the participation and the organization of concerts. The company launched a new web/mobile-platform where artists and venues promote concerts. The platform is also available for iPhone and Android Mobile. Stagend.com has won the Startups.ch Award in 2011.
Stagend.com announced today that it has secured CHF100’000 seed funding from the AGIRE Foundation. The team is now discussing with several investors about a series A and is still open to new interested VCs or Business Angels.
AGIRE is a non-profit organization and acts as Ticino’s platform for the transfer of technologies and knowledge. Its members are the Canton Ticino, the University of Southern Switzerland (USI), the Universityof Applied Sciences and Arts of Southern Switzerland (SUPSI), the Association of Ticino manufacturers (AITI), the Ticino Chamber of Commerce, Industry, Handicraft and Services (Cc-TI), the local agencies for development (ERS) and the city of Lugano.
AGIRE's mission is to promote innovation and entrepreneurship in Ticino. It focuses on the support of existing companies and of new companies that can lead to the creation of high-skilles jobs and support the economic development of the Cantone Ticino.
Swiss start-up turns to the Nasdaq
Last year Auris Medical raised more than CHF47 million in venture capital for further growth. This was the largest round of financing in Switzerland in 2013. The company has two drugs in development: an injection for tinnitus and a drug for hearing loss in the inner ear. The tinnitus medication has already started the third and most expensive stage of development, the phase III trial. The Basel company, which has its headquarters in Zug, intends to raise the necessary capital on the Nasdaq: the IPO should bring Auris a total of $95 million in new money.